Homosomic males from the chromosome 19 consomic strain 129S1/SvImJ-Chr19MOLF/Ei/NadJahe (also called 129.MOLF-Chr19 or M19) exhibit ~75% spontaneous testicular germ cell tumors (TGCTs). These mice are useful for studying susceptibility to TGCT - the most common solid tumors in human males aged 15–34.
This strain represents one of a panel of inter-species chromosome substitution (or consomic) strains. Each strain carries a chromosome from the Mus musculus molossinus wild-derived strain MOLF/Ei introgressed into a Mus musculus domesticus 129S1/SvImJ background. These strains provide a tool for dissection of quantitative trait loci.
Jason D Heaney, Baylor College of Medicine
The chromosome 19 consomic strain 129S1/SvImJ-Chr19MOLF/Ei/NadJahe (also called 129.MOLF-Chr19 or M19) represents one of a panel of inter-species chromosome substitution (or consomic) strains. Each strain carries a chromosome from the Mus musculus molossinus wild-derived strain MOLF/Ei introgressed into a Mus musculus domesticus 129S1/SvImJ background. The MOLF strain is separated from the common inbred strain progenitors by approximately 100,000 years. These strains represent a tool for dissection of quantitative trait loci.
The M19 mice are useful for studying genetic susceptibility to testicular germ cell tumors (TGCTs) - the most common solid tumors in human males aged 15–34. Homosomic and heterozygous M19 males have a spontaneous TGCT rate of ~75% and ~25%, respectively, whereas the incidence ~5% in 129S1/SvImJ males. Spontaneous TGCTs have not been observed in MOLF/Ei. For homosomic M19 males, unilateral and bilateral primary tumors are observed, and putative metastases have been reported. M19 males are fertile, but may exhibit some breeding difficulties if large tumors are present (details below). For homosomic M19 females, there is no evidence for reduced fertility (no germ cell defects have been detected).
Whereas 129 mice homozygous for the Dnd1Ter mutation (129T1/Sv-Oca2+ Tyrc-ch Dnd1Ter/J ; Stock No. 000091) have a TGCT incidence of ~90% and are also deficient for normal germ cells, these homosomic M19 males show most germ cells develop normally. Thus, both normal and transformed germ cells are present in the M19 testis, and M19 males can be fertile despite having testicular tumors.
In M19 males, the window of TGCT initiation is during embryogenesis (embryonic day (E)12.5-15.5). ~75% of M19 males develop tumors in utero and that incidence does not increase with age. At E15.5, the tumor stem cells (pluripotent embryonal carcinoma [EC] cells) first appear and form foci of cells. By E18.5, the EC cells have started to differentiate into cell types derived from all three embryonic germ layers (teratoma). Histologically, various stages of tumor progression are visible from ~E15.5 onward. The donating investigator reports that gross visual observation of testicular tumors is reliable by 6-8 weeks of age. Tumors grow for a while after birth, but because they ultimately form mature teratomas (i.e., contain fully differentiated cell types), the cells eventually become quiescent and the tumor stops growing (or may even regress). Tumor size is random: some adult males exhibit very large tumors - but this has no correlation with advancing age.
Multiple TGCT susceptible loci have been mapped to chromosome 19 of the M19 strain. These loci either act independently or interact epistatically to contribute to testicular tumor development. Susceptibility genes/variants exist in both the donor (MOLF/Ei) and host (129S1/SvImJ) genome. Several publications examine M19 testicular germ cell tumor quantitative trait loci and/or specific genes (Youngren et al. 2003 Hum Mol Genet 12:389,
Zhu et al. 2007 Mamm Genome 18:584 and
Zhu et al. 2010 Cancer Res 70:7264).
The laboratory of Dr. Joseph Nadeau (Case Western Reserve University) developed the 129S1/SvImJ-Chr #MOLF/Ei/Nad strain set by replacing individual chromosomes from the MOLF/Ei donor strain into the 129S1/SvImJ host strain using a marker-assisted series of backcrosses.
Using this approach, the chromosome 19 consomic strain 129S1/SvImJ-Chr19MOLF/Ei/NadJahe (also called 129.MOLF-Chr19 or M19) was created by Dr. Angabin Matin while in the laboratory of Dr. Nadeau. At backcross generations three and four, females with non-recombinant MOLF/Ei-derived chromosome 19 were crossed with 129S1/SvImJ males - thus the Y chromosome of the consomic strain is of 129S1/SvImJ origin. After working with the M19 mice in Dr. Nadeau's lab, Dr. Jason D. Heaney transferred the mice to Baylor College of Medicine in 2012. From there, homosomic mice (both females and males) with agouti coat color were sent to The Jackson Laboratory in 2017.
Currently there are no related genes or alleles for this strain.
This chromosome 19 consomic strain 129S1/SvImJ-Chr19MOLF/Ei/NadJahe (also called 129.MOLF-Chr19 or M19) is maintained as homozygous (homosomic) for the MOLF/Ei-derived chromosome 19 by sibling matings.
Homosomic and heterozygous M19 males have a spontaneous testicular germ cell tumor (TGCT) rate of ~75% and ~25%, respectively, and are fertile despite having testicular tumors. However, homosomic males may exhibit some breeding difficulties if large tumors are present. For homosomic M19 females, there is no evidence for reduced fertility (no germ cell defects have been detected). In general, mouse lines on the 129 genetic background typically have smaller litters sizes.
When using the 129.MOLF-Chr19 consomic (or M19) mouse strain in a publication, please cite the originating article(s) and include JAX stock #029319 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Homozygous for Chr 19<MOLF/Ei> 1pr minimum |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.